Share chart Neuland Laboratories Limited
About Neuland Laboratories Limited
Neuland Laboratories Limited производит и продает активные фармацевтические ингредиенты (АФИ) в Индии, Европе, США и за рубежом. АФИ компании используются в различных терапевтических областях, включая противоастматические, сердечно-сосудистые, противогрибковые, противосудорожные средства, средства для центральной нервной системы, фторхинолоны, антипсихотические, антибактериальные и противопаркинсонические средства. Он также предоставляет индивидуальные производственные решения, а также услуги по синтезу пептидов. more detailsMain settings
ISIN
INE794A01010
Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Валюта отчета
inr
Див.доход ао
0.1296
Дивиденд ао
14
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 5.26 | 2 |
| P/BV | 6.39 | 1 |
| P/E | 27.3 | 6 |
Efficiency
| Title | Value | Grade |
| ROA | 17.59 | 5 |
| ROE | 26.36 | 8 |
| ROIC | 15.71 | 5 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0.1296 | 0.33 |
| DSI | 0.9286 | 9.29 |
| Average dividend growth | 23.1 | 10 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 0.2009 | 10 |
| Debt/Ratio | 0.0521 | 10 |
| Debt/Equity | 0.4287 | 10 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 105.69 | 10 |
| Yield Ebitda, % | 374.98 | 10 |
| Yield EPS, % | 1751.86 | 10 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 11 322 ₹ | 0 ₹ | 0 ₹ | -1.83 % | 0 % | 0 % |
| Week | 11 151 ₹ | 0 ₹ | 0 ₹ | -0.32 % | 0 % | 0 % |
| Month | 12 300 ₹ | 11 056 ₹ | 12 587 ₹ | -9.63 % | 0 % | 0 % |
| Three month | 11 601.2 ₹ | 10 797.4 ₹ | 13 136 ₹ | -4.19 % | 0 % | 0 % |
| Half a year | 16 068.9 ₹ | 10 487.3 ₹ | 16 954.65 ₹ | -30.83 % | 0 % | 0 % |
| Year | 6 327.6 ₹ | 6 275.3 ₹ | 17 846.35 ₹ | 75.66 % | 0 % | 0 % |
| 3 years | 1 070.85 ₹ | 1 028.6 ₹ | 17 846.35 ₹ | 937.96 % | 0 % | 0 % |
| 5 years | 438.15 ₹ | 403.5 ₹ | 17 846.35 ₹ | 2436.8 % | 0 % | 0 % |
| 10 years | 0 ₹ | 255.35 ₹ | 17 846.35 ₹ | 0 % | 0 % | 0 % |
| Year to date | 14 428.2 ₹ | 10 487.3 ₹ | 14 881.8 ₹ | -22.96 % | 0 % | 0 % |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Dr. Davuluri Rama Mohan Rao | Executive Chairman & Chief Promoter and Member of Scientific Advisory Board | 60M | 1944 (81 year) |
| Mr. Davuluri Sucheth Rao | Vice Chairman & CEO | 57.5M | 1975 (50 years) |
| Mr. Davuluri Saharsh Rao | Vice Chairman & MD | 57.5M | 1979 (46 years) |
| Mr. Abhijit Majumdar | Chief Financial Officer | N/A | |
| Ms. Sarada Bhamidipati | Company Secretary & Compliance Officer | N/A | |
| Mr. Y. Sudheer | Senior Vice President of Global API Sales | N/A | 1963 (62 years) |
| Dr. Sharadsrikar Venkatesan Kotturi | Chief Scientific Officer & Member of Scientific Advisory Board | ||
| Mr. Sudheer Yarabolu | Senior VP of Global Head Sales & BD | ||
| Mr. Hemchandra Peruvelli | Chief Human Resources Officer | 1972 (53 years) | |
| Mr. N. Sundar | Chief Procurement Officer | 1968 (57 years) |
About company
Address: India, Hyderabad, Phoenix IVY Building - Open in google maps, Open in yandex maps
Website: https://www.neulandlabs.com
Website: https://www.neulandlabs.com
